BioNumerik Pharmaceuticals, Inc.
6 clinical trials · Sponsor
◉ Watch BioNumerik Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin (NCT00966914) | BioNumerik Pharmaceuticals, Inc. | 2010-04-01 |
| Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer (NCT00477282) | BioNumerik Pharmaceuticals, Inc. | 2007-08-01 |
| Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer (NCT00097903) | BioNumerik Pharmaceuticals, Inc. | 2004-05-01 |
| Study of Karenitecin (BNP1350) to Treat Malignant Melanoma (NCT00062491) | BioNumerik Pharmaceuticals, Inc. | 2002-05-01 |
| Study of Karenitecin (BNP1350) in Patients With Brain Tumors (NCT00062478) | BioNumerik Pharmaceuticals, Inc. | 2001-10-01 |
| Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel (NCT00039780) | BioNumerik Pharmaceuticals, Inc. | 2001-09-01 |
Track BioNumerik Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.